In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Zosano Pharma Corp (NASDAQ:ZSAN) reported that Rosalind Advisors, Inc. has picked up 2,083,100 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by Rosalind Advisors, Inc. to a total of 2,083,100 representing a 5.5% stake in the company.
For those not familiar with the company, Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability. The Company’s short-wear-time transdermal patch consists of an array of titanium microneedles that is coated with its formulation of an approved drug and attached to an adhesive patch. When the patch is applied with its hand-held applicator, the microneedles painlessly penetrate the skin, resulting in rapid dissolution and absorption of the drug coating through the capillary bed. Its product candidates include ZP-Triptan, ZP-Glucagon and ZP-PTH. ZP-PTH is a formulation of teriparatide, a synthetic form of parathyroid hormone. ZP-Glucagon is a formulation of glucagon.
A glance at Zosano Pharma Corp (NASDAQ:ZSAN)’s key stats reveals a current market capitalization of 62.47 Million based on 33.82 Million shares outstanding and a price at last close of $1.88 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-08-19, Erbez picked up 47,750 at a purchase price of $1.32. This brings their total holding to 47,750 as of the date of the filing.
On the sell side, the most recent transaction saw Barrett unload 1,099,996 shares at a sale price of $2.01. This brings their total holding to 952,809.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Zosano Pharma Corp (NASDAQ:ZSAN) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.